
Profound Medical Corp experienced a significant uptick in its stock price, reflecting investor optimism.
In yesterday's trading session, Profound Medical Corp (PRN.TO) saw its stock price soar by 13.29%, closing at CA$11.76. This surge marks a notable rebound for the company, which has faced challenges in the past.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
Market cap
$377.18M
52W high
$12.40
52W low
$5.23
1W change
+14.51%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 112.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+112.8% Upside
Current Price
C$11.76
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
54.4%
Annualized
90-Day Vol
53.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$14.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$12.48 | C$10.34 – C$15.06 |
| 60 trading days | C$13.25 | C$10.16 – C$17.28 |
| 90 trading days | C$14.06 | C$10.16 – C$19.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may want to consider the implications of this recent price movement and the company's upcoming financial results as potential catalysts for future performance.
Profound Medical Corp's stock jumped 13.29% yesterday.
The company's market cap now stands at approximately CA$427 million, reflecting renewed interest from investors.
Bull case
The recent increase in stock price suggests that investors are becoming more confident in Profound Medical's innovative technologies and their potential impact on the market. This is especially true with major medical conferences approaching, where the company will showcase its advancements.
Bear case
Even with the positive movement, investors should stay cautious. Profound Medical has faced setbacks in clinical trials, which could impact long-term growth prospects.
Advertisement
Understanding the Surge
The 13.29% increase in Profound Medical's stock price can be attributed to a mix of factors, including positive market sentiment and anticipation of future developments. Investors are particularly focused on the company's upcoming financial results, which are set to be released on August 6, 2026. This announcement could provide further clarity on the company's performance and strategic direction.
Market Reaction and Future Outlook
The surge in stock price reflects a broader trend of investor optimism within the healthcare sector, particularly in companies that are innovating in medical technology. However, potential investors should weigh this positive momentum against the backdrop of past challenges, such as the recent CAPTAIN trial results. As Profound Medical continues to develop its TULSA-PRO® system and prepares for key presentations, the market will be closely watching for any indications of sustained growth.
Advertisement
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


